HES up +1.37% percent right now. $HES High is at 85.99 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
HES up +1.37% percent right now. $HES High is at 85.99 and the Low 83.74 with current volume of 4,306,600.

Recent News posted below.

HES Hess Corp Recent Headline News

Low Oil Prices Won’t Stop Hess, Others From Investing Billions in Gulf of Mexico
at The Street - Thu Nov 06, 9:09AM CST
The Gulf of Mexico continues to attract oil producers from all around the world, despite tumbling crude oil prices. Here’s why.
HES: 84.86 (+1.15), CVX: 118.80 (+0.27), STO: 22.46 (+0.49)

Interim Changes, Quarterly Results, Technical Update, and Investments - Research Reports on Petroleo Brasileiro, Hess, BP, Devon Energy and Alcoa
PR Newswire - Thu Nov 06, 8:10AM CST
Today, Analysts Review released its research reports regarding Petroleo Brasileiro Petrobras SA (NYSE: PBR), Hess Corporation (NYSE: HES), BP p.l.c. (NYSE: BP), Devon Energy Corporation (NYSE: DVN) and Alcoa Inc. (NYSE: AA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7758-100free.
DVN: 65.03 (+2.47), PBR: 10.90 (+0.17), AA: 16.33 (-0.04), HES: 84.86 (+1.15), BP: 42.06 (+0.19)

Oil and Gas Firms Turn to Technology to Weather Low Energy Prices
at The Street - Wed Nov 05, 12:46PM CST
Lower energy prices are delaying capital spending and highlighting the need for advanced technology. Is that the new golden goose for E&P companies?
RDS.A: 71.00 (+1.54), HES: 84.86 (+1.15), TOT: 58.13 (+0.10), NBR: 17.70 (+0.53), WFT: 15.67 (+0.29), XOM: 96.59 (+0.33), DD: 70.41 (+0.29), COP: 72.16 (+0.84), BP: 42.06 (+0.19), GLRI: 4.90 (+0.14), SLB: 98.73 (+1.75)

'Mad Money' Lightning Round: Buy, Buy, Buy Lockheed Martin
at The Street - Wed Nov 05, 5:00AM CST
Cramer says Leucadia National is too dangerous for him, hold on to General Electric but wait on ConocoPhillips and Hess.
LUK: 23.80 (-0.06), LMT: 186.15 (-3.73), GE: 26.41 (+0.05), ACAD: 27.69 (-0.25), HES: 84.86 (+1.15), COP: 72.16 (+0.84)

Jim Cramer's 'Mad Money' Recap: Why Are Money Managers Making Things So Complicated?
at The Street - Tue Nov 04, 7:31PM CST
The smart money is buying, not selling, on the current low oil prices, Cramer insists.
LUK: 23.80 (-0.06), GPRO: 79.06 (+0.30), TMST: 39.04 (+1.35), LMT: 186.15 (-3.73), GE: 26.41 (+0.05), ACAD: 27.69 (-0.25), HES: 84.86 (+1.15), FB: 75.60 (+0.34), COP: 72.16 (+0.84), GOOGL: 551.82 (+0.13), TWTR: 40.31 (-0.53)

Hess Falls 2.19% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Tue Nov 04, 4:36PM CST
Hess (NYSE:HES) traded in a range yesterday that spanned from a low of $79.88 to a high of $81.73. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $81.66 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HES: 84.86 (+1.15)

Hess Set to Possibly Rebound After Yesterday's Selloff of 2.19%
Comtex SmarTrend(R) - Tue Nov 04, 4:36PM CST
Hess (NYSE:HES) traded in a range yesterday that spanned from a low of $79.88 to a high of $81.73. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $81.66 on volume of 3.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HES: 84.86 (+1.15)

Oil Price Cut by Saudis Could Provide Sector a Much-Needed Boost
at The Street - Tue Nov 04, 11:45AM CST
The decline in oil prices is causing the Saudis to consider different ways to prop up demand for its oil. Will this latest move work?
HES: 84.86 (+1.15), CVX: 118.80 (+0.27), STO: 22.46 (+0.49)

Hess to Host Investor Day
Business Wire - Mon Nov 03, 12:30PM CST
Hess Corporation (NYSE:HES) will hold an Investor Day on November 10, 2014 at 1:00 p.m. CST in Houston, TX.
HES: 84.86 (+1.15)

Exxon, Chevron Show Keeping Refineries Has More Value Than Breakup
at The Street - Mon Nov 03, 12:01PM CST
Pressure to break up energy companies to boost shareholder value may lift valuations but may not help companies in the long term.
HES: 84.86 (+1.15), XOM: 96.59 (+0.33), COP: 72.16 (+0.84), MRO: 34.39 (+0.05), CVX: 118.80 (+0.27)

Offshore Drilling: Big News Out of the Gulf of Mexico
Matt DiLallo, The Motley Fool - Motley Fool - Sat Nov 01, 9:30AM CDT
BP's Thunder Horse platform in the Gulf of Mexico. Source: BP p.l.c. Last week, the big news in offshore drilling was the gusher of offshore discoveries around the world . One of the highlights was the discovery of the Guadalupe oil...
HES: 84.86 (+1.15), BP: 42.06 (+0.19), CVX: 118.80 (+0.27)

Oil and Gas Spending Cuts Throw Spotlight on Bakken, Eagle Ford
at The Street - Sat Nov 01, 7:15AM CDT
Spending cuts are hard to ignore in the energy sector, but these shale plays may still be areas of growth for investors.
MUR: 54.53 (+1.48), HES: 84.86 (+1.15), CHK: 23.41 (+0.65), EOG: 99.55 (+0.58), XOM: 96.59 (+0.33), COP: 72.16 (+0.84), CRZO: 53.38 (+3.54), OXY: 88.04 (+1.64), CVX: 118.80 (+0.27), SWN: 36.50 (+0.95), STO: 22.46 (+0.49)

After Yesterday's Rally of 2.01% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Fri Oct 31, 4:15PM CDT
Hess (NYSE:HES) traded in a range yesterday that spanned from a low of $82.10 to a high of $85.06. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $84.97 on volume of 4.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HES: 84.86 (+1.15)

Watch for Hess to Potentially Pullback After Gaining 2.01% Yesterday
Comtex SmarTrend(R) - Fri Oct 31, 4:15PM CDT
Hess (NYSE:HES) traded in a range yesterday that spanned from a low of $82.10 to a high of $85.06. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $84.97 on volume of 4.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
HES: 84.86 (+1.15)

Upgrade Alert for Hess (HES)
Comtex SmarTrend(R) - Fri Oct 31, 7:13AM CDT
Hess (NYSE:HES) was upgraded from Hold to Buy at ISI Group (pre-open) today. The stock closed yesterday at $83.16 on volume of 2.3 million shares, below average daily volume of 3.5 million. In the past 52 weeks, Hess share prices have been bracketed by a low of $72.86 and a high of $104.50 and closed yesterday at $83.14, 14% above that low price. The 200-day and 50-day moving averages have moved 0.06% higher and 1.44% lower over the past week, respectively.
HES: 84.86 (+1.15)

Hess (HES) Earnings Report: Q3 2014 Conference Call Transcript
at The Street - Thu Oct 30, 1:02PM CDT
The following Hess (HES) conference call took place on October 29, 2014, 10:00 AM ET. This is a transcript of that earnings call:
HES: 84.86 (+1.15)

Company News for October 30, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 9:10AM CDT
Companies in the News are: ETN,HES,PX,MHFI
ETN: 69.17 (+0.11), HES: 84.86 (+1.15), MHFI: 89.94 (-0.05), PX: 126.67 (+0.10)

Marathon Petroleum Beats Earnings on Improved Margins - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 9:06AM CDT
Marathon Petroleum Corp. (MPC) reported strong third-quarter results, owing to higher product price realization and improved crack spread.
MPLX: 69.91 (+1.54), HES: 84.86 (+1.15), MPC: 94.08 (+0.95), MUSA: 59.41 (+0.40)

Hess Reports $1 Billion Third-Quarter Earnings, Tubular Bells Offshore Project to Start Production, an Industrial Info News Alert
Marketwired - Thu Oct 30, 5:15AM CDT
Researched by Industrial Info Resources (Sugar Land, Texas) -- Oil and gas exploration and production company Hess Corporation (NYSE:HES) (New York, New York) reported its third-quarter net income rose to more than $1 billion from $440 million a year earlier, reflecting the sale of its downstream retail business. Adjusted net income, which excludes items affecting comparability, was $377 million, compared with $405 million in the year-ago quarter. Industrial Info is tracking 23 Hess projects worth $4.04 billion.
HES: 84.86 (+1.15), WMB: 55.38 (+0.67), CVX: 118.80 (+0.27)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading